News

FIGS heads into Q2 earnings with product innovation, global expansion and demand momentum in focus, while tariffs and freight costs may have pressured margins.

CMG's second-quarter results reflect benefits from positive comparable sales, restaurant expansion and stronger digital engagement.

YUM tops earnings estimates as Taco Bell's strong sales and global expansion help offset softer Pizza Hut performance.

SBUX's shares jump after fiscal third-quarter adjusted earnings beat estimates, comparable sales rise and management lifts fiscal 2026 guidance.

FIGS stock has returned 77.6% over the past year, yet the valuation checks are sending mixed signals as the Discounted Cash Flow (DCF) intrinsic value estimate points to some upside while earnings based multiples lean the other way. Over the last 12 months FIGS has delivered a 77.6% share price gain, which puts added focus on whether that rerating is backed up by fundamentals. Recent optimism around earnings prospects, highlighted by an analyst upgrade, can support the intrinsic value case...

Figs (FIGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

FIGS' stronger revenue outlook and customer growth support the bull case, but its big rally, richer valuation and cost pressure complicate the buy call.

A number of stocks jumped in the afternoon session after oil prices fell on hopes of a US-Iran peace deal.

If you are wondering whether FIGS at US$11.66 is offering good value or just pricing in a lot of optimism, the next steps are all about putting some structure around that question. The stock has returned 2.0% over the last week, 0.3% over the past month, 2.4% year to date, 124.2% over the last year, 34.8% over three years and a decline of 65.7% over five years, giving you a mix of strong recent gains and a longer term reset to think about. Recent headlines have focused on FIGS as a...

In early June 2026, FIGS reported quarterly results that surpassed analyst expectations, highlighting broad-based sales growth, improving margins, and strong cash flow across its healthcare apparel business. These results underline how FIGS’ product innovation and disciplined operations are supporting both reinvestment in growth initiatives and ongoing returns to shareholders. Now we’ll explore how this stronger-than-expected profitability performance may reshape FIGS’ existing investment...

One company powers healthcare apparel with direct sales and rapid growth, while the other scales global basics with steady cash flow and lower valuations.

A number of stocks jumped in the afternoon session after easing pressure in the bond market and a pullback in oil prices boosted investor sentiment for consumer-facing companies.

FIGS, Inc. (NYSE:FIGS) is one of the 8 Best Small Cap US Stocks to Buy. On May 7, 2026, FIGS, Inc. (NYSE:FIGS) reported Q1 EPS of 3c, versus the consensus estimate of 2c. Revenue totaled $159.9M, versus the consensus estimate of $153.14M. Active customers as of March 31 increased 12.2% year over year to 3.0M, […]

Figs (FIGS) delivered earnings and revenue surprises of +125.56% and +5.05%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

FIGS, GAP and CPRI enter the earnings season with strong momentum, margin discipline and positive ESPs, signaling potential earnings surprises.

BLDR Q1 EPS misses estimates as sales fall 10%. Sales, however, beat forecasts. The new 2026 outlook turns cautious while buybacks expand.

UPBD Q1 earnings beat on Brigit subscriber growth, margin expansion and strong cash flow, even as revenues slightly miss estimates.